Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: Facts and speculations

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2193-2206

  Scanu, Angelo M ^a,b   Edelstein, Celina ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apolipoprotein a ; Fragments; Inflammation and atherosclerosis; MiniLp a ,; PMN elastase

Indexed keywords

ELASTASE;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; LIPOLYSIS; LIPOPROTEIN METABOLISM; NEUTROPHIL; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; APOLIPOPROTEIN B-100; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CARBOHYDRATE SEQUENCE; DISULFIDES; HUMANS; KRINGLES; LEUKOCYTE ELASTASE; LIPOPROTEIN(A); MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PANCREATIC ELASTASE; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 0030699284     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. McLean, J. W., J. E. Tomlinson, W. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein[a] is homologous to plasminogen. Nature. 330: 132-137.
2. Utermann, G. 1995. Lipoprotein[a]. In The Metabolic and Molecular Basis of Inherited Disease. C. R. Scriver, A. Beaudet, W. S. Sly and D. Valle, editors. McGraw Hill, Inc. New York. NY. 1887-1912.
3. Scanu, A. M., and C. Edelstein. 1995. Kringle-dependent structural and functional polymorphism of apolipoprotein[a]. Biochim. Biophys. Acta. 1256: 1-12.
4. Lawn, M. R., and A. M. Scanu. 1996. Lipoprotein[a]. In Atherosclerosis and Coronary Artery Disease. R. R. V. Fuster, and E. J. Topol, editors. Lippincott-Raven, Philadelphia, PA. 151-161.
5. Scanu, A. M. 1993. Structural basis for the presumptive atherothrombogenic action of lipoprotein[a] - facts and speculations. Biochem. Pharmacol. 46: 1675-1680.
6. Gries, A., J. Nimpf, M. Nimpf, H. Wurm, and G. M. Kostner. 1987. Free and apoB-associated Lp[a]-specific protein in human serum. Clin. Chim. Acta. 164: 93-100.
7. Koschinsky, M. L., J. E. Tomlinson, T. F. Zioncheck, K. Schwartz, D. L. Eaton, and R. M. Lawn. 1991. Apolipoprotein[a] - expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 30: 5044-5051.
8. Edelstein, C., M. Mandala, D. Pfaffinger, and A. M. Scanu. 1995. Determinants of lipoprotein[a] assembly: a study of wild-type and mutant apolipoprotein[a] phenotypes isolated from human and rhesus monkey lipoprotein[a] under mild reductive conditions. Biochemistry. 34: 16483-16492.
9. Klezovitch, O., C. Edelstein, and A. M. Scanu. 1996. Evidence that the fibrinogen binding domain of apo[a] is outside the lysine binding site (LBS) of kringle IV-10. A study involving naturally occurring lysine binding-defective lipoprotein[a] phenotypes. J. Clin. Invest. 98: 185-191.
10. Mooser, V., S. M. Marcovina, A. L. White, and H. H. Hobbs. 1996. Kringle-containing fragments of apolipoprotein[a] circulate in human plasma and are excreted into the urine. J. Clin. Invest. 98: 2414-2424.
11. Oida, K., H. Takai, H. Maeda, S. Takahashi, A. Shimada, J. Suzuki, T. Tamai, T. Nakai, and S. Miyabo. 1992. Apolipoprotein[a] is present in urine and its excretion is decreased in patients with renal failure. Clin. Chem. 38: 2244-2248.
12. Mooser, V., M. C. Seabra, M. Abedin, K. T. Landschulz, S. Marcovina, and H. H. Hobbs. 1996. Apolipoprotein[a] kringle4-containing fragments in human urine. Relationship to plasma levels of lipoprotein[a]. J. Clin. Invest. 97: 858-864.
13. Hoff, H. F., J. Oneil, G. B. Smejkal, and A. Yashiro. 1994. Immunochemically detectable lipid-free apo[a] in plasma and in human atherosclerotic lesions. Chem. Phys. Lipids. 67: 271-280.
14. Fless, G. M. 1990. Heterogeneity of particles containing the apoB-apo[a] complex. In Lipoprotein[a]. A. M. Scanu, editor. Academic Press, Inc., New York, NY. 41-51.
15. Pfaffinger, D., J. Schuelke, C. Kim, G. M. Fless, and A. M. Scanu. 1991. Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal. J. Lipid Res. 32: 679-683.
16. Utermann, G. 1989. The mysteries of lipoprotein[a]. Science. 246: 904-910.
17. Lackner, C., J. C. Cohen, and H. H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein[a]. Hum. Mol. Genet. 2: 933-940.
18. Gaubatz, J. W., C. Heideman, A. M. Gotto, Jr., J. D. Morrisett, and G. H. Dahlen. 1983. Human plasma lipoprotein[a]: structural properties. J. Biol. Chem. 258: 4582-4589.
19. Magnusson, S., T. E. Peterson, L. Sottrup-Jensen, and H. Claeys. 1975. Complete primary structure of prothrombin. Isolation, structure, and reactivity of ten carboxylated glutamic acid residues and regulation of prothrombin activation by thrombin. In Proteases and Biological Control. E. Reich, D. B. Rifkin, and E. Shaw, editors., Cold Spring Harbor Laboratories, Cold Spring Harbor, NY. 123-149.
20. Kraft, H. G., S. Kochl, H. J. Menzel, C. Sandholzer, and G. Utermann. 1992. The apolipoprotein[a] gene - a transcribed hypervariable locus controlling plasma lipoprotein[a] concentration. Hum. Genet. 90: 220-230.
21. Lindahl, G., E. Gersdorf, H. J. Menzel, M. Seed, S. Humphries, and G. Utermann. 1990. Variation in the size of human apolipoprotein[a] is due to a hypervariable region in the gene. Hum. Genet. 84: 563-567.
22. Gavish, D., N. Azrolan, and J. L. Breslow. 1989. Plasma Lp[a] concentration is inversely correlated with the ratio of kringle IV/kringle V encoding domains in the apo[a] gene. J. Clin. Invest. 84: 2021-2027.
23. Lackner, C., E. Boerwinkle, C. C. Loffert, T. Rahmig, and H. H. Hobbs. 1991. Molecular basis of apolipoprotein[a] isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87: 2153-2161.
24. Ichinose, A. 1995. Characterization of the apolipoprotein[a] gene. Biochem. Biophys. Res. Commun. 209: 365-371.
25. Peterson, T. K., M. R. Martzen, A. Ichinose, and E. W. Davie. 1990. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J. Biol. Chem. 265: 6104-6111.
26. Pathy, L. 1985. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell. 41: 657-663.
27. Tomlinson, J., J. McLean, and R. Lawn. 1989. Rhesus monkey apolipoprotein[a]. J. Biol. Chem. 264: 5957-5965.
28. McCormick, S. P. A., J. K. No, S. Taylor, L. M. Flynn, R. E. Hammer, and S. G. Young. 1995. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein[a]. Proc. Natl. Acad. Sci. USA. 92: 10147-10151.
29. Fless, G. M., M. E. ZumMallen, and A. M. Scanu. 1986. Physicochemical properties of apolipoprotein[a] and lipoprotein[a-] derived from the dissociation of human plasma lipoprotein[a]. J. Biol. Chem. 261: 8712-8718.
30. Nakamura, T., T. Nishizawa, and M. Hagiya. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342: 440-443.
31. Hoover-Plow, J. L., L. A. Miles, G. M. Fless, A. M. Scanu, and E. F. Plow. 1993. Comparison of the lysine binding functions of lipoprotein[a] and plasminogen. Biochemistry. 32: 13681-13687.
32. Ernst, E. 1992. Fibrinogen, a cardiovascular risk factor. Clin. Hermorheol. 12: 805-816.
33. Klezovitch, O., and A. M. Scanu. 1996. Lysine and fibrinogen binding of wild type (Trp72) and mutant (Arg72) human apolipoprotein[a] kringle IV-10 expressed in E. coli and CHO cells. Arterioscler. Thromb. 16: 392-398.
34. Hansen, J. E., O. Lund, K. Rapacki, and S. Brunak. 1997. O-GLYCBASE version 2.0: a revised database of O-glycosylated proteins. Nucleic Acid Res. 25: 278-282.
35. Ernst, A., M. Helmhold, C. Brunner, A. Pethoschramm, V. W. Armstrong, and H. J. Muller. 1995. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein[a]. J. Biol. Chem. 270: 6227-6234.
36. Edelstein, C., J. A. Italia, O. Klezovitch, and A. M. Scanu. 1996. Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]. J. Lipid Res. 37: 1786-1801.
37. Edelstein, C., J. I. Italia, and A. M. Scanu. 1997. Polymorphonuclear cells isolated from human peripheral blood cleave Lp[a] and apo[a] at multiple interkringle sites via the enzyme elastase: generation of miniLp[a] particles and apo[a] fragments. J. Biol. Chem. 272: 11079-11087.
38. Powers, J. C., B. F. Gupton, A. D. Harley, N. Nishino, and R. J. Whitley. 1977. Specificity of porcine elastase, human leukocyte elastase and cathepsin G: inhibition with peptide chloromethyl ketones. Biochim. Biophys. Acta. 485: 156-166.
39. Yoshimura, K., and R. G. Crystal. 1992. Transcriptional and posttranslational modulation of human neutrophil elastase gene expression. Blood. 79: 2733-2740.
40. Takahashi, H., T. Nukiwa, K. Yoshimura, C. D. Quick, D. J. States, M. D. Holmes, J. Peng-Whang, T. Knutsen, and R. G. Crystal. 1988. Structure of the human neutrophil elastase gene. J. Biol. Chem. 263: 14739-14747.
41. Huby, T., C. Doucet, H. Dieplinger, J. Chapman, and J. Thillet. 1994. Structural domains of of apolipoprotein [a] and its interaction with apolipoprotein B-100 in the lipoprotein[a] particle. Biochemistry. 33: 3335-3341.
42. Huby, T., W. Schroder, C. Doucet, J. Chapman, and J. Thillett. 1995. Characterization of the N-terminal and C-terminal domains of human apolipoprotein[a]: relevance to fibrin binding. Biochemistry. 34: 7385-7393.
43. Malech, H. L., and J. I. Gallin. 1987. Neutrophils in human disease. N. Engl. J. Med. 317: 687-694.
44. Henson, P. M., and R. B. J. Johnston. 1987. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J. Clin. Invest. 79: 669-673.
45. Kostner, K. M., G. Maurer, K. Huber, T. Stefenelli, H. Dieplinger, E. Steyrer, and G. M. Kostner. 1996. Urinary excretion of apo[a] fragments: role in apo[a] catabolism. Arterioscler. Thromb. Vasc. Biol. 16: 905-911.
46. Kostner, K. M., M. Jansen, G. Maurer, and K. Derfler. 1997. LDL-apheresis significantly reduces urinary apo[a] excretion. Eur. J. Clin. Invest. 27: 93-95.
47. Fallon, J. T. 1996. Pathology of myocardial infarction and reperfusion. In Atherosclerosis and Coronary Artery Disease. R. R. V. Faster, E. J. Topol, editors. Lippincott-Raven, Philadelphia, PA. 791-796.
48. Ross, R., and V. Fuster. 1996. The pathogenesis of atherosclerosis. In Atherosclerosis and Coronary Artery Disease. R. R. V. Fuster, E. J. Topol, editors. Lippincott-Raven, Philadelphia, PA. 441-460.
49. Kling, D., T. Holzschuh, and E. Betz. 1993. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening - a comparative study with normoand hypercholestrolemic rabbits. Atherosclerosis. 101: 79-96.
50. Sweetnam, P. M., H. F. Thomas, J. W. G. Yamell, I. A. Baker, and P. C. Elwood. 1997. Total and differential leukocyte counts as predictors of ischemic heart disease. Am. J. Epidemiol. 145: 416-421.
51. Haverkate, F., S. G. Thompson, S. D. M. Pyke, J. R. Gallimore, and M. B. Pepys. 1997. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349: 462-466.
52. Ridker, P. M., M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336: 973-979.
53. Buja, L. M. 1996. Does atherosclerosis have an infectious etiology? Circulation. 94: 872-873.
54. Grayston, J. T. 1993. Chlamydia in atherosclerosis. Circulation. 87: 1408-1409.
55. Saikku, P., M. Leinonen, and L. Tenkanen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116: 273-278.
56. Thom, D. H., J. T. Grayston, D. S. Siscovick, S. P. Wang, N. S. Weiss, and J. R. Daling. 1992. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J. Am. Med. Assoc. 268: 68-72.
57. Melnick, J. E., E. Adam, and M. E. DeBakey. 1990. Possible role of cytomegalovirus in atherogenesis. J. Am. Med. Assoc. 263: 2204-2207.
58. Mendall, M. A., P. M. Goggin, and N. Molineaux. 1994. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 71: 437-439.
59. Patel, P., M. A. Mendall, and D. Carrington. 1995. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. 311: 711-714.
60. Maeda, S., A. Abe, M. Seishima, K. Makino, A. Noma, and M. Kawade. 1989. Transient changes of serum Ep[a] as an acute phase protein. Atherosclerosis. 78: 145-150.
61. Noma, A., A. Abe, S. Maeda, M. Seishima, K. Makino, Y. Yano, and K, Shimokawa. 1994. Lp[a] - an acute-phase reactant. Chem. Phys. Lipids. 67: 411-417.
62. Kario, K., T. Matsuo, H. Kobayashi, M. Matsuo, R. Asada, and M. Koide. 1995. High lipoprotein [a] levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb. Haemostasis. 74: 1020-1024.
63. Edelstein, C., J. A. Italia, O. Klezovitch, and A. M. Scanu. 1997. Metalloproteinase-2 cleaves lipoprotein[a] and apolipoprotein[a] in the linker region between kringles 4 and 5. Circulation. In press.
64. Cushing, G. E., J. W. Gaubatz, M. E. Nava, B. J. Burdick, T. M. A. Bocan, J. R. Guvton, D. Weilbaecher, M. E. Debakey, G. M. Laurie, and J. D. Morrisett. 1988. Quantification and localization of apoproteins[a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis. 9: 593-603.
65. Pepin, J. M., J. A. Oneil, and H. F. Hoff. 1991. Quantification of apo[a] and apoB in human atherosclerotic Lesions. J. Lipid Res. 32: 317-327.
66. Rath, M., A. Niendorf, T. Reblin, M. Dietel, H. J. Krebber, and U. Beisiegel. 1989. Detection and quantification of lipoprotein[a] in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 9: 579-592.
67. Polacek, D., R. E. Byrne, and A. M. Scanu. 1988. Modification of low density lipoproteins by polymorphonuclear cell elastase leads to enhanced uptake by human monocyte-derived macrophages via the low density lipoprotein receptor pathway. J. Lipid Res. 29: 797-808.
68. Chisolm, G. M., and M. S. Penn. 1996. Oxidized lipoproteins and atherosclerosis. In Atherosclerosis and Coronary Artery Disease. R. R. V. Fuster, E.J. Topol, editors. Lippincott-Raven, Philadelphia. 129-149.
69. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witzum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
70. Hajjar, H. A., D. Gavish, J. E. Breslow, and R. L. Nachman. 1989. Lipoprotein[a] modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 339: 303-305.
71. Miles, L. A., G. M. Fless, E. G. Levine, A. M. Scanu, and E. F. Plow. 1989. A potential role for the thrombotic risks associated with lipoprotein[a]. Nature. 339: 301-303.
72. Palabrica, T. M., A. C. Liu, M. J. Aronovitz, B. Furie, R. M. Lawn, and B. C. Furie. 1995. Antifibrinolytic activity of apolipoprotein[a] in vivo: human apolipoprotein[a] transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nature Med. 1: 256-259.
73. Grainger, D. J., H. L. Kirschenlohr, J. C. Metcalfe, P. L. Weissberg, D. P. Wade, and R. M. Lawn. 1993. Proliferation of human smooth muscle cells promoted by lipoprotein[a]. Science. 260: 1655-1658.
74. Grainger, D. L., P. R. Kemp, A. C. Liu, R. M. Lawn, and J. C. Metcalfe. 1994. Activation of transforming factor-β is inhibited in transgenic apolipoprotein[a] mice. Nature. 370: 460-462.
75. Gibbons, G., R. Pratt, and V. Dzau. 1992. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine TGF-BB-1 expression determines growth response to angiotensin II. J. Clin. Invest. 90: 456-461.
76. Battegay, E., E. Raines, R. A. Seifert, D. F. Bowen-Pope, and R. Ross. 1990. TGF-BB induces bimodal proliferation ot connective tissue cells via complex control of an autocrine PDGF loop. Cell. 63: 515-524.
77. Majesky, M. W., V. Lindner, D. R. Twardzig, S. M. Schwatz, and M. A. Reidy. 1991. Production of transforming growth factor β-1 during repair of arterial injury. J. Clin. Invest. 88: 904-910.
78. Cowan, B., O. Baron, J. Crack, C. Coulber, G. J. Wilson, and M. Rabinovitch. 1996. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits after heterotopic cardiac transplantation. J. Clin. Invest. 97: 2452-2468.
79. White, A. L., B. Guerra, and R. E. Lanford. 1997. Influence of allelic variation on apolipoprotein[a] folding in the endoplasmic reticulum. J. Biol. Chem. 272: 5048-5055.
80. Hoover-Plow, J. L., N. Boonmark, P. Skocir, R. Lawn, and E. F. Plow. 1996. A quantitative immunoassay for the lysine-binding function of lipoprotein[a]: application to recombinant apo[a] and lipoprotein[a] in plasma. Arterioscler. Thrornb. Vasc. Biol. 16: 656-663.
81. Karmansky, I., H. Shnader, A. Palant, and N. Gruener. 1994. Lysine-binding species of lipoprotein[a] in coronary artery disease. Eur. J. Clin. Invest. 24: 360-366.
82. Fless, G. M., and Snyder, M. L. 1994. Polymorphic forms of Lp[a] with different structural and functional properties: cold-induced self-association and binding to fibrin and lysine-Sepahrose. Chem. Phys. Lipids. 67: 69-79.
83. Hervio, L., M. J. Chapman, J. Thillet, S. Loyau, and E. Anglés-Cano. 1993. Does apolipoprotein[a] heterogeneity influence lipoprotein[a] effects on fibrinolysis. Blood. 82: 392-397.
84. Leerink, C. B., P. F. C. C. M. Duif, N. Verhoeven, C. M. Hackeng, F. R. Leus, J. Prins, B. N. Bouma, and H. J. M. Vanrijn. 1994. Apolipoprotein[a] isoform size influences binding of lipoprotein[a] to plasmin-modified des-AA-fibrinogen. Fibrinolysis. 8: 214-220.
85. Sandholzer, C., E. Boerwinkle, N. Saha, M. C. Tong, and G. Utermann. 1992. Apolipoprotein[a] phenotypes, Lp[a] concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo[a] gene in coronary heart disease. J. Clin. Invest. 89: 1040-1046.
86. Farrer, M., F. L. Game, C. J. Albers, H. A. W. Neil, P. H. Winocour, M. F. Laker, P. C. Adams, K. George, and K. G. M. M. Alberti. 1994. Coronary artery disease is associated with increased lipoprotein[a] concentrations independent of the size of circulating apolipoprotein[a] isoforms. Arterioscler. Thromb. 14: 1272-1283.
87. Wild, S. H., S. P. Fortmann, and S. M. Marcovina. 1997. A prospective case-control study of lipoprotein[a] levels and apo[a] size and risk of coronary heart disease in Stanford five-city project participants. Arterioscler. Thromb. Vasc. Biol. 17: 239-245.
88. Kraft, H. G., A. Lingenhel, S. Köchl, F. Höppichler, F. Krönenberg, A. Abe, V. Mühlberger, D. Schonitzer, and G. Utermann. 1996. Apolipoprotein[a] kringle IV repeat number predicts risk for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 16: 713-719.
89. Scann, A. M., and Fless, G. M. 1990. Lipoprotein [a]: heterogeneity and biological relevance. J. Clin. Invest. 85: 1709-1715.
90. Chou, P. Y., and G. D. Fasman. 1978. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47: 251-276.
91. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120: 97-120.